These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2694113)

  • 41. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome).
    Felbamate Study Group in Lennox-Gastaut Syndrome
    N Engl J Med; 1993 Jan; 328(1):29-33. PubMed ID: 8347179
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The clinical pharmacokinetics of the new antiepileptic drugs.
    Perucca E
    Epilepsia; 1999; 40 Suppl 9():S7-13. PubMed ID: 10612356
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Simultaneous determination of felbamate and three metabolites in human plasma by high-performance liquid chromatography.
    Romanyshyn LA; Wichmann JK; Kucharczyk N; Sofia RD
    Ther Drug Monit; 1994 Feb; 16(1):83-9. PubMed ID: 8160261
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetic profile of topiramate in comparison with other new antiepileptic drugs.
    Perucca E
    Epilepsia; 1996; 37 Suppl 2():S8-S13. PubMed ID: 8641245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determination of felbamate in human serum by high-performance liquid chromatography.
    Annesley TM; Clayton LT
    Ther Drug Monit; 1994 Aug; 16(4):419-24. PubMed ID: 7974634
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Felbamate pharmacokinetics in the rat, rabbit, and dog.
    Adusumalli VE; Yang JT; Wong KK; Kucharczyk N; Sofia RD
    Drug Metab Dispos; 1991; 19(6):1116-25. PubMed ID: 1687019
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Simultaneous determination of felbamate and three metabolites in rat and dog plasmas by high-performance liquid chromatography.
    Romanyshyn LA; Wichmann JK; Kucharczyk N; Sofia RD
    J Chromatogr; 1993 Dec; 622(2):229-34. PubMed ID: 8150870
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term use of felbamate: clinical outcomes and effect of age and concomitant antiepileptic drug use on its clearance.
    White JR; Leppik IE; Beattie JL; Walczak TS; Tran TA; Rarick JO; Vaher P
    Epilepsia; 2009 Nov; 50(11):2390-6. PubMed ID: 19563346
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is there any future for felbamate treatment?
    Borowicz KK; Piskorska B; Kimber-Trojnar Z; Małek R; Sobieszek G; Czuczwar SJ
    Pol J Pharmacol; 2004; 56(3):289-94. PubMed ID: 15215558
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Felbamate metabolism in pediatric and adult beagle dogs.
    Yang JT; Morris M; Wong KK; Kucharczyk N; Sofia RD
    Drug Metab Dispos; 1992; 20(1):84-8. PubMed ID: 1347002
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug concentrations in human brain tissue samples from epileptic patients treated with felbamate.
    Adusumalli VE; Wichmann JK; Kucharczyk N; Kamin M; Sofia RD; French J; Sperling M; Bourgeois B; Devinsky O; Dreifuss FE
    Drug Metab Dispos; 1994; 22(1):168-70. PubMed ID: 8149879
    [No Abstract]   [Full Text] [Related]  

  • 52. [Therapeutic drug monitoring of felbamate].
    Tribut O; Bentué-Ferrer D; Verdier MC;
    Therapie; 2010; 65(1):35-8. PubMed ID: 20205993
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of felbamate on plasma levels of carbamazepine and its metabolites.
    Albani F; Theodore WH; Washington P; Devinsky O; Bromfield E; Porter RJ; Nice FJ
    Epilepsia; 1991; 32(1):130-2. PubMed ID: 1985822
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative pharmacokinetics of the newer antiepileptic drugs.
    Bialer M
    Clin Pharmacokinet; 1993 Jun; 24(6):441-52. PubMed ID: 8513648
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of AUCs from sparsely sampled populations in toxicology studies.
    Pai SM; Fettner SH; Hajian G; Cayen MN; Batra VK
    Pharm Res; 1996 Sep; 13(9):1283-90. PubMed ID: 8893263
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part II. Phenytoin, carbamazepine, sulthiame, lamotrigine, vigabatrin, oxcarbazepine and felbamate.
    Battino D; Estienne M; Avanzini G
    Clin Pharmacokinet; 1995 Nov; 29(5):341-69. PubMed ID: 8582119
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The synthesis, in vitro reactivity, and evidence for formation in humans of 5-phenyl-1,3-oxazinane-2,4-dione, a metabolite of felbamate.
    Thompson CD; Miller TA; Barthen MT; Dieckhaus CM; Sofia RD; Macdonald TL
    Drug Metab Dispos; 2000 Apr; 28(4):434-9. PubMed ID: 10725312
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?
    Johannessen SI; Tomson T
    Clin Pharmacokinet; 2006; 45(11):1061-75. PubMed ID: 17048972
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Measurement of felbamate by wide-bore capillary gas chromatography and flame ionization detection.
    Rifai N; Fuller D; Law T; Mikati M
    Clin Chem; 1994 May; 40(5):745-8. PubMed ID: 8174245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.